Related Experiment Video
Updated: Mar 29, 2026

TAPE: A Biodegradable Hemostatic Glue Inspired by a Ubiquitous Compound in Plants for Surgical Application
Published on: June 8, 2016
Dual-Functionality of Polysaccharide-based Hemostatic Powder: Effective Bleeding Control and Adhesion Reduction in
Lukasz Szymanski1,2, Patrycja Krakowiak2, Zuzanna Walas2
1Department of Molecular Biology, Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, Magdalenka, Poland.
None:
Postoperative adhesions are a frequent and serious complication of abdominal and pelvic surgeries, leading to chronic pain, infertility, and intestinal obstruction, with significant clinical, and economic burdens. While barrier agents are widely used for prevention, current solutions often suffer from limited efficacy and short retention times. This study evaluates the dual-functionality of a polysaccharide-based medical device, 4SEAL Hemostatic Powder, by evaluating hemostatic performance and the reduction of postoperative adhesions. Using rat models, the hemostatic efficacy of 4SEAL was assessed via a standardized liver incision protocol, while its anti-adhesive properties were compared to hyaluronic acid and saline controls following ovariohysterectomy. Outcomes measured included time to hemostasis, number and severity of adhesions, and comprehensive histological, hematological, biochemical, and metabolic analyses to assess safety and tissue response. In addition, the absorption profile of 4SEAL, in both gel and powder forms, was evaluated using a murine model. 4SEAL Hemostatic Powder significantly shortened time to hemostasis (2.14±0.39 min vs. 4.30±2.02 min for untreated controls, p = 0.003) and decreased both the number of adhesions (powder: 0.85±0.75, gel: 1.0±0.92 vs. 2.9±1.29 for controls, p<0.01) and adhesion severity (powder: 3.75±2.67, gel: 3.55±3.19 vs. 7.7±4.88 for controls, p<0.05). Hyaluronic acid reduced adhesion number (1.6±2.27, p<0.05) but not severity (4.8±4.44, not statistically significant). Histological analysis indicated more advanced tissue regeneration and lower levels of fibrosis in 4SEAL-treated animals. No significant systemic biochemical or metabolic alterations were observed in the 4SEAL groups, supporting its biocompatibility. The findings indicate that 4SEAL Hemostatic Powder is effective in promoting hemostasis and reducing postoperative adhesion formation in preclinical models. The material demonstrated biocompatibility and biodegradability, supporting its potential utility as a dual-function surgical adjunct.
Related Concept Videos
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

